PL Development’s First ANDA Adds Ibuprofen Manufacturing As Growth Driver
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves private label firm PL Developments’ ANDA to make store brand ibuprofen in its manufacturing facility, giving the firm more control over its supply chain and possible market share gains against national brands and other generics providers, says President Evan Singer.